Abiomed (FRA:AIO) Interest Expense : €0 Mil (TTM As of Sep. 2022)

View and export this data going back to 1987. Start your Free Trial

What is Abiomed Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Abiomed's interest expense for the three months ended in Sep. 2022 was € 0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2022 was €0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Abiomed's Operating Income for the three months ended in Sep. 2022 was € 59 Mil. Abiomed's Interest Expense for the three months ended in Sep. 2022 was € 0 Mil. Abiomed has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Abiomed Interest Expense Historical Data

The historical data trend for Abiomed's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abiomed Interest Expense Chart

Abiomed Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Interest Expense

Get a 7-Day Free Trial

Abiomed Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Abiomed Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Abiomed (FRA:AIO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abiomed's Interest Expense for the three months ended in Sep. 2022 was €0 Mil. Its Operating Income for the three months ended in Sep. 2022 was €59 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2022 was €0 Mil.

Abiomed's Interest Coverage for the quarter that ended in Sep. 2022 is calculated as

Abiomed had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Abiomed Inc has no debt.

Abiomed (FRA:AIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abiomed Inc (FRA:AIO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

22 Cherry Hill Drive, Danvers, MA, USA, 01923

Website

https://www.abiomed.com

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.